JP2011188872A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011188872A5 JP2011188872A5 JP2011148711A JP2011148711A JP2011188872A5 JP 2011188872 A5 JP2011188872 A5 JP 2011188872A5 JP 2011148711 A JP2011148711 A JP 2011148711A JP 2011148711 A JP2011148711 A JP 2011148711A JP 2011188872 A5 JP2011188872 A5 JP 2011188872A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- cell
- interleukin
- dendritic cells
- immature dendritic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000427 antigen Substances 0.000 claims 32
- 108091007433 antigens Proteins 0.000 claims 32
- 102000036639 antigens Human genes 0.000 claims 32
- 210000004443 dendritic cell Anatomy 0.000 claims 31
- 238000000034 method Methods 0.000 claims 22
- 238000000338 in vitro Methods 0.000 claims 10
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 6
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 6
- 102000004388 Interleukin-4 Human genes 0.000 claims 6
- 108090000978 Interleukin-4 Proteins 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 230000001580 bacterial effect Effects 0.000 claims 6
- 230000004069 differentiation Effects 0.000 claims 6
- 229940028885 interleukin-4 Drugs 0.000 claims 6
- 239000002243 precursor Substances 0.000 claims 6
- 210000004027 cell Anatomy 0.000 claims 5
- 210000001744 T-lymphocyte Anatomy 0.000 claims 4
- 230000035800 maturation Effects 0.000 claims 4
- 102000003814 Interleukin-10 Human genes 0.000 claims 3
- 108090000174 Interleukin-10 Proteins 0.000 claims 3
- 102000013462 Interleukin-12 Human genes 0.000 claims 3
- 108010065805 Interleukin-12 Proteins 0.000 claims 3
- 102000003816 Interleukin-13 Human genes 0.000 claims 3
- 108090000176 Interleukin-13 Proteins 0.000 claims 3
- 239000013592 cell lysate Substances 0.000 claims 3
- 238000012258 culturing Methods 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000012528 membrane Substances 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 210000004881 tumor cell Anatomy 0.000 claims 3
- 102000008070 Interferon-gamma Human genes 0.000 claims 2
- 108010074328 Interferon-gamma Proteins 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 229960003130 interferon gamma Drugs 0.000 claims 2
- 210000005260 human cell Anatomy 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 229940076144 interleukin-10 Drugs 0.000 claims 1
- 229940117681 interleukin-12 Drugs 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31759201P | 2001-09-06 | 2001-09-06 | |
| US60/317,592 | 2001-09-06 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003526345A Division JP2005505270A (ja) | 2001-09-06 | 2002-09-06 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015040165A Division JP6114768B2 (ja) | 2001-09-06 | 2015-03-02 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011188872A JP2011188872A (ja) | 2011-09-29 |
| JP2011188872A5 true JP2011188872A5 (OSRAM) | 2012-10-18 |
| JP5777956B2 JP5777956B2 (ja) | 2015-09-16 |
Family
ID=32654226
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003526345A Pending JP2005505270A (ja) | 2001-09-06 | 2002-09-06 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
| JP2011148711A Expired - Fee Related JP5777956B2 (ja) | 2001-09-06 | 2011-07-04 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
| JP2015040165A Expired - Fee Related JP6114768B2 (ja) | 2001-09-06 | 2015-03-02 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003526345A Pending JP2005505270A (ja) | 2001-09-06 | 2002-09-06 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015040165A Expired - Fee Related JP6114768B2 (ja) | 2001-09-06 | 2015-03-02 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20050059151A1 (OSRAM) |
| EP (3) | EP2322603B1 (OSRAM) |
| JP (3) | JP2005505270A (OSRAM) |
| KR (3) | KR20050027163A (OSRAM) |
| CN (2) | CN102973928B (OSRAM) |
| AU (1) | AU2008221592B2 (OSRAM) |
| BR (1) | BRPI0212545B8 (OSRAM) |
| CA (1) | CA2459713C (OSRAM) |
| DK (2) | DK1441591T3 (OSRAM) |
| ES (2) | ES2766299T3 (OSRAM) |
| IL (3) | IL160720A0 (OSRAM) |
| MX (1) | MXPA04002147A (OSRAM) |
| NO (2) | NO338147B1 (OSRAM) |
| NZ (1) | NZ531530A (OSRAM) |
| PL (1) | PL372098A1 (OSRAM) |
| PT (2) | PT1441591T (OSRAM) |
| WO (1) | WO2003022215A2 (OSRAM) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT412145B (de) * | 2002-09-13 | 2004-10-25 | Forsch Krebskranke Kinder | Verfahren zur herstellung eines zellulären immuntherapeutikums auf basis von il-12-freisetzenden dendritischen zellen |
| US20040057935A1 (en) * | 2002-09-20 | 2004-03-25 | Cedars-Sinai Medical Center | Intratumoral delivery of dendritic cells |
| BRPI0317064B8 (pt) * | 2002-12-06 | 2021-05-25 | Northwest Biotherapeutics Inc | composições compreendendo células dendríticas parcialmente amadurecidas in vitro |
| AU2004214896A1 (en) * | 2003-02-27 | 2004-09-10 | Northwest Biotherapeutics, Inc. | Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines |
| EP1484064A1 (en) | 2003-06-04 | 2004-12-08 | Gesellschaft für Biotechnologische Forschung | Therapeutical composition containing dentritic cells and use thereof |
| WO2005037995A2 (en) * | 2003-10-06 | 2005-04-28 | Cedars-Sinai Medical Center | Use of cox-2 inhibitor to prevent t-cell anergy induced by dendritic cell therapy |
| WO2005043155A1 (en) * | 2003-10-21 | 2005-05-12 | Cedars-Sinai Medical Center | System and method for the treatment of cancer, including cancers of the central nervous system |
| JPWO2005042737A1 (ja) * | 2003-11-04 | 2007-05-10 | 株式会社ディナベック研究所 | 遺伝子導入された樹状細胞の製造方法 |
| KR20070028573A (ko) | 2004-06-24 | 2007-03-12 | 가부시키가이샤 디나벡크 겐큐쇼 | 마이너스 가닥 ｒｎａ 바이러스를 포함하는 항암제 |
| KR20220113543A (ko) * | 2005-12-08 | 2022-08-12 | 노쓰웨스트 바이오써라퓨틱스, 인크. | 미성숙 단핵구성 수지상 세포의 활성화를 유도하기 위한 조성물 및 방법 |
| EP1840206A1 (en) * | 2006-03-28 | 2007-10-03 | Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh | Compositions for the preparation of mature dendritic cells |
| WO2008039874A2 (en) | 2006-09-26 | 2008-04-03 | Cedars-Sinai Medical Center | Cancer stem cell antigen vaccines and methods |
| WO2008039974A2 (en) | 2006-09-28 | 2008-04-03 | Cedars-Sinai Medical Center | Cancer vaccines and vaccination methods |
| DK2328923T3 (en) | 2008-09-02 | 2016-03-21 | Cedars Sinai Medical Center | CD133 epitopes |
| PL2427485T3 (pl) * | 2009-05-07 | 2017-10-31 | Immunocellular Therapeutics Ltd | Epitopy CD133 |
| JP2015506698A (ja) * | 2012-02-02 | 2015-03-05 | カリフォルニア ステム セル インコーポレイテッド | 多能性胚葉起源抗原を提示する癌ワクチン |
| CN104379730B (zh) * | 2012-05-31 | 2016-12-14 | Jw可瑞基因株式会社 | 使树突细胞成熟的组合物以及用其制备抗原特异性树突细胞的方法 |
| US20140065173A1 (en) | 2012-09-06 | 2014-03-06 | Orbis Health Solutions Llc | Tumor lysate loaded particles |
| AU2020203845C1 (en) * | 2012-09-06 | 2022-08-11 | Orbis Health Solutions, Llc | Tumor lysate loaded particles |
| EP2931324B1 (en) | 2012-12-12 | 2018-09-19 | Orbis Health Solutions LLC | Compositions and methods for tissue regeneration |
| CA2898474A1 (en) | 2013-02-14 | 2014-08-21 | Immunocellular Therapeutics, Ltd. | Cancer vaccines and vaccination methods |
| CN112891522A (zh) * | 2013-09-05 | 2021-06-04 | 奥比思健康解决方案有限责任公司 | 装载了肿瘤裂解物的微粒 |
| US10166195B2 (en) | 2014-03-05 | 2019-01-01 | Orbis Health Solutions, Llc | Vaccine delivery systems using yeast cell wall particles |
| US9646428B1 (en) | 2014-05-20 | 2017-05-09 | State Farm Mutual Automobile Insurance Company | Accident response using autonomous vehicle monitoring |
| US9972054B1 (en) | 2014-05-20 | 2018-05-15 | State Farm Mutual Automobile Insurance Company | Accident fault determination for autonomous vehicles |
| US10373259B1 (en) | 2014-05-20 | 2019-08-06 | State Farm Mutual Automobile Insurance Company | Fully autonomous vehicle insurance pricing |
| US10599155B1 (en) | 2014-05-20 | 2020-03-24 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle operation feature monitoring and evaluation of effectiveness |
| US11669090B2 (en) | 2014-05-20 | 2023-06-06 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle operation feature monitoring and evaluation of effectiveness |
| US10540723B1 (en) | 2014-07-21 | 2020-01-21 | State Farm Mutual Automobile Insurance Company | Methods of providing insurance savings based upon telematics and usage-based insurance |
| US10831204B1 (en) | 2014-11-13 | 2020-11-10 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle automatic parking |
| EP3317402B1 (en) | 2015-06-30 | 2024-02-14 | Universidade Nova de Lisboa | A viable cell population, method for production and uses thereof |
| EP4574159A3 (en) * | 2015-06-30 | 2025-09-17 | NorthWest Biotherapeutics, Inc. | Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response |
| US20210258486A1 (en) | 2015-08-28 | 2021-08-19 | State Farm Mutual Automobile Insurance Company | Electric vehicle battery conservation |
| US11719545B2 (en) | 2016-01-22 | 2023-08-08 | Hyundai Motor Company | Autonomous vehicle component damage and salvage assessment |
| US10395332B1 (en) | 2016-01-22 | 2019-08-27 | State Farm Mutual Automobile Insurance Company | Coordinated autonomous vehicle automatic area scanning |
| US10324463B1 (en) | 2016-01-22 | 2019-06-18 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle operation adjustment based upon route |
| US11441916B1 (en) | 2016-01-22 | 2022-09-13 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle trip routing |
| US10384678B1 (en) | 2016-01-22 | 2019-08-20 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle action communications |
| US10134278B1 (en) | 2016-01-22 | 2018-11-20 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle application |
| US11242051B1 (en) | 2016-01-22 | 2022-02-08 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle action communications |
| KR102038114B1 (ko) * | 2016-02-26 | 2019-10-30 | 주식회사 엘지화학 | 광학 점착제용 (메타)아크릴레이트기 함유 벤조페논의 제조방법 및 광학 점착제 조성물 |
| WO2018160666A1 (en) * | 2017-02-28 | 2018-09-07 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Short-term activated dc1s and methods for their production and use |
| WO2019183924A1 (en) * | 2018-03-30 | 2019-10-03 | Syz Cell Therapy Co. | Improved multiple antigen specific cell therapy methods |
| WO2021071977A1 (en) * | 2019-10-07 | 2021-04-15 | Northwest Biotherapeutics, Inc. | In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5162504A (en) | 1988-06-03 | 1992-11-10 | Cytogen Corporation | Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients |
| US5366866A (en) * | 1991-07-25 | 1994-11-22 | Duke University | Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies OXA and OXB |
| US5227471A (en) * | 1992-01-30 | 1993-07-13 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Monoclonal antibody PD41 that binds to a prostate mucin antigen that is expressed in human prostatic carcinoma |
| US5788963A (en) | 1995-07-31 | 1998-08-04 | Pacific Northwest Cancer Foundation | Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| EP0871487B1 (en) * | 1995-10-04 | 2009-05-27 | Immunex Corporation | Dendritic cell stimulatory factor |
| US7659119B2 (en) * | 1996-02-12 | 2010-02-09 | Argos Therapeutics, Inc. | Method and compositions for obtaining mature dendritic cells |
| ATE428769T1 (de) * | 1997-10-27 | 2009-05-15 | Univ Rockefeller | Methode und zusammensetzung zur herstellung von reifen dendritischen zellen |
| JP2000143534A (ja) * | 1998-11-13 | 2000-05-23 | Asahi Chem Ind Co Ltd | 樹状細胞ワクチン及びその製造方法 |
| JP2000279181A (ja) * | 1999-04-01 | 2000-10-10 | Japan Science & Technology Corp | ヒト樹状細胞の発現遺伝子群 |
| WO2001048154A1 (en) * | 1999-12-28 | 2001-07-05 | Toyoshima, Kumao | Maturation-promoting agent for immature dendritic cells |
| US6247378B1 (en) * | 2000-01-06 | 2001-06-19 | Deere & Company | Operator control device for an infinitely variable transmission |
| EP2363139B1 (en) * | 2000-05-12 | 2016-03-02 | NorthWest Biotherapeutics, Inc. | Method to increase class I presentation of exogenous antigens by human dendritic cells |
| DE60117167T2 (de) * | 2001-01-15 | 2006-10-05 | I.D.M. Immuno-Designed Molecules | Verfahren zur herstellung von submikropartikel-suspensionen pharmazeutischer substanzen |
| AU2002326463A1 (en) * | 2001-07-25 | 2003-02-17 | Northwest Biotherapeutics, Inc. | Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors |
-
2002
- 2002-09-06 ES ES10181985T patent/ES2766299T3/es not_active Expired - Lifetime
- 2002-09-06 BR BRPI0212545A patent/BRPI0212545B8/pt not_active IP Right Cessation
- 2002-09-06 CN CN201210470111.XA patent/CN102973928B/zh not_active Expired - Fee Related
- 2002-09-06 EP EP10181985.2A patent/EP2322603B1/en not_active Expired - Lifetime
- 2002-09-06 EP EP02761594.7A patent/EP1441591B1/en not_active Expired - Lifetime
- 2002-09-06 CN CN028198174A patent/CN1636229B/zh not_active Expired - Fee Related
- 2002-09-06 KR KR1020047003386A patent/KR20050027163A/ko not_active Ceased
- 2002-09-06 CA CA2459713A patent/CA2459713C/en not_active Expired - Lifetime
- 2002-09-06 JP JP2003526345A patent/JP2005505270A/ja active Pending
- 2002-09-06 PL PL02372098A patent/PL372098A1/xx not_active Application Discontinuation
- 2002-09-06 ES ES02761594.7T patent/ES2598109T3/es not_active Expired - Lifetime
- 2002-09-06 PT PT2761594T patent/PT1441591T/pt unknown
- 2002-09-06 EP EP19202820.7A patent/EP3653055A1/en not_active Withdrawn
- 2002-09-06 KR KR1020117012621A patent/KR20110081341A/ko not_active Ceased
- 2002-09-06 DK DK02761594.7T patent/DK1441591T3/en active
- 2002-09-06 NZ NZ531530A patent/NZ531530A/en not_active IP Right Cessation
- 2002-09-06 DK DK10181985.2T patent/DK2322603T3/da active
- 2002-09-06 MX MXPA04002147A patent/MXPA04002147A/es active IP Right Grant
- 2002-09-06 US US10/488,744 patent/US20050059151A1/en not_active Abandoned
- 2002-09-06 PT PT101819852T patent/PT2322603T/pt unknown
- 2002-09-06 IL IL16072002A patent/IL160720A0/xx unknown
- 2002-09-06 WO PCT/US2002/028620 patent/WO2003022215A2/en not_active Ceased
- 2002-09-06 KR KR1020147023675A patent/KR101803702B1/ko not_active Expired - Lifetime
-
2004
- 2004-03-03 IL IL160720A patent/IL160720A/en active IP Right Grant
- 2004-03-05 NO NO20040965A patent/NO338147B1/no not_active IP Right Cessation
-
2008
- 2008-05-29 US US12/129,549 patent/US20080254064A1/en not_active Abandoned
- 2008-09-19 AU AU2008221592A patent/AU2008221592B2/en not_active Ceased
-
2011
- 2011-07-04 JP JP2011148711A patent/JP5777956B2/ja not_active Expired - Fee Related
-
2012
- 2012-04-18 IL IL219266A patent/IL219266A/en active IP Right Grant
-
2015
- 2015-03-02 JP JP2015040165A patent/JP6114768B2/ja not_active Expired - Fee Related
- 2015-11-16 NO NO20151562A patent/NO20151562A1/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011188872A5 (OSRAM) | ||
| JP2005505270A5 (OSRAM) | ||
| Van Driessche et al. | Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial | |
| JP2014511704A5 (OSRAM) | ||
| IL273516B2 (en) | Methods of isolating t cells having antigenic specificity for a p53 cancer-specific mutation | |
| Yanagibashi et al. | Bacteroides induce higher IgA production than Lactobacillus by increasing activation-induced cytidine deaminase expression in B cells in murine Peyer’s patches | |
| CN103533955A (zh) | 用于激发t细胞的方法 | |
| JPWO2020243561A5 (OSRAM) | ||
| JP2012518409A5 (OSRAM) | ||
| JP2011500592A5 (OSRAM) | ||
| AR080585A1 (es) | Vacunacion contra tumores que comprende una respuesta inmune humoral contra proteinas propias | |
| WO2022052984A1 (en) | Universal sars-cov-2 vaccine and preparation method thereof | |
| Larssen et al. | Allogenicity boosts extracellular vesicle–induced antigen-specific immunity and mediates tumor protection and long-term memory in vivo | |
| CN112048001B (zh) | 一种肿瘤新生抗原多肽及其应用 | |
| KR101770785B1 (ko) | 종양 세포 증식 억제를 위해 개선된 조성물 | |
| JP2020534313A5 (OSRAM) | ||
| JP2010538649A5 (OSRAM) | ||
| Shi et al. | Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro | |
| JP2010538619A5 (OSRAM) | ||
| Shaulov et al. | CD8 T cell expansion and memory differentiation are facilitated by simultaneous and sustained exposure to antigenic and inflammatory milieu | |
| JP2011522835A5 (OSRAM) | ||
| Gedvilaite et al. | Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells | |
| Tegerstedt et al. | Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor | |
| Ni et al. | Antitumor vaccination by Newcastle Disease Virus Hemagglutinin–Neuraminidase plasmid DNA application: Changes in tumor microenvironment and activation of innate anti-tumor immunity | |
| JP2025504109A (ja) | Ｅｂｖ複合抗原、樹状細胞ワクチンおよびその使用 |